Cargando…
Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery
BACKGROUND: The aim of this study is to identify prognostic factors and the best candidates for neoadjuvant therapy among patients with resectable left-sided pancreatic ductal adenocarcinoma (PDAC) by analyzing the timing and pattern of recurrence following upfront surgery. METHODS: This single-cent...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638787/ https://www.ncbi.nlm.nih.gov/pubmed/36353584 http://dx.doi.org/10.21037/gs-22-304 |
_version_ | 1784825501865476096 |
---|---|
author | Lee, Seung Jae Hwang, Dae Wook Lee, Jae Hoon Song, Ki Byung Lee, Woohyung Park, Yejong Kim, Song Cheol |
author_facet | Lee, Seung Jae Hwang, Dae Wook Lee, Jae Hoon Song, Ki Byung Lee, Woohyung Park, Yejong Kim, Song Cheol |
author_sort | Lee, Seung Jae |
collection | PubMed |
description | BACKGROUND: The aim of this study is to identify prognostic factors and the best candidates for neoadjuvant therapy among patients with resectable left-sided pancreatic ductal adenocarcinoma (PDAC) by analyzing the timing and pattern of recurrence following upfront surgery. METHODS: This single-center retrospective study included patients with resectable left-sided PDAC who underwent upfront distal pancreatectomy from 2005 to 2015. A minimum P value approach was used to evaluate the optimal cutoff of early recurrence. The predictors of recurrence were assessed with Cox regression analysis. RESULTS: Among 311 included patients, 241 (77.5%) had a recurrence at a median follow-up of 29.3 months. Systemic recurrence occurred in 194 patients (80.5%) and isolated local recurrence in 47 patients (19.5%). A recurrence-free survival cutoff of 12 months was selected to distinguish between early and late recurrence. The patients with early recurrence had a shorter median overall survival (16.1 vs. 39.9 months, P<0.001) and post-recurrence survival (9.6 vs. 17.2 months, P<0.001) than those with late recurrence. The patients with systemic recurrence had a shorter median overall survival (19.6 vs. 29.1 months, P=0.007) and post-recurrence survival (11.0 vs. 15.3 months, P=0.024) than those with an isolated local recurrence. In multivariable analysis, preoperative CA 19-9 ≥500 U/mL [odd ratio (OR) 2.037, P=0.035], radiologic splenic vessels invasion (OR 5.014, P<0.001), positive radial resection margin (OR 2.638, P<0.001), and no adjuvant chemotherapy (OR 2.084, P=0.001) were predictors of an early systemic recurrence. CONCLUSIONS: Radiologic splenic vessels invasion may be considered to indicate a biologically borderline status in patients with anatomically resectable left-sided PDAC. Future clinical trials of neoadjuvant therapy targeting these patients should be conducted. |
format | Online Article Text |
id | pubmed-9638787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-96387872022-11-08 Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery Lee, Seung Jae Hwang, Dae Wook Lee, Jae Hoon Song, Ki Byung Lee, Woohyung Park, Yejong Kim, Song Cheol Gland Surg Original Article BACKGROUND: The aim of this study is to identify prognostic factors and the best candidates for neoadjuvant therapy among patients with resectable left-sided pancreatic ductal adenocarcinoma (PDAC) by analyzing the timing and pattern of recurrence following upfront surgery. METHODS: This single-center retrospective study included patients with resectable left-sided PDAC who underwent upfront distal pancreatectomy from 2005 to 2015. A minimum P value approach was used to evaluate the optimal cutoff of early recurrence. The predictors of recurrence were assessed with Cox regression analysis. RESULTS: Among 311 included patients, 241 (77.5%) had a recurrence at a median follow-up of 29.3 months. Systemic recurrence occurred in 194 patients (80.5%) and isolated local recurrence in 47 patients (19.5%). A recurrence-free survival cutoff of 12 months was selected to distinguish between early and late recurrence. The patients with early recurrence had a shorter median overall survival (16.1 vs. 39.9 months, P<0.001) and post-recurrence survival (9.6 vs. 17.2 months, P<0.001) than those with late recurrence. The patients with systemic recurrence had a shorter median overall survival (19.6 vs. 29.1 months, P=0.007) and post-recurrence survival (11.0 vs. 15.3 months, P=0.024) than those with an isolated local recurrence. In multivariable analysis, preoperative CA 19-9 ≥500 U/mL [odd ratio (OR) 2.037, P=0.035], radiologic splenic vessels invasion (OR 5.014, P<0.001), positive radial resection margin (OR 2.638, P<0.001), and no adjuvant chemotherapy (OR 2.084, P=0.001) were predictors of an early systemic recurrence. CONCLUSIONS: Radiologic splenic vessels invasion may be considered to indicate a biologically borderline status in patients with anatomically resectable left-sided PDAC. Future clinical trials of neoadjuvant therapy targeting these patients should be conducted. AME Publishing Company 2022-10 /pmc/articles/PMC9638787/ /pubmed/36353584 http://dx.doi.org/10.21037/gs-22-304 Text en 2022 Gland Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Lee, Seung Jae Hwang, Dae Wook Lee, Jae Hoon Song, Ki Byung Lee, Woohyung Park, Yejong Kim, Song Cheol Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title | Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title_full | Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title_fullStr | Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title_full_unstemmed | Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title_short | Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
title_sort | impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638787/ https://www.ncbi.nlm.nih.gov/pubmed/36353584 http://dx.doi.org/10.21037/gs-22-304 |
work_keys_str_mv | AT leeseungjae impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT hwangdaewook impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT leejaehoon impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT songkibyung impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT leewoohyung impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT parkyejong impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery AT kimsongcheol impactofradiologicsplenicvesselinvasioninresectableleftsidedpancreaticductaladenocarcinomapredictorofearlysystemicrecurrencefollowingupfrontsurgery |